Elegen is bringing unique insights and technical innovation to create high-quality synthetic DNA faster, catalyzing the next revolution in the life sciences. The company is led by seasoned leaders with decades of experience developing novel and scalable approaches in molecular biology, chemistry and microfluidics. Elegen uses a proprietary microfluidics approach to build longer, higher-quality DNA […]
Headquartered in Seattle and Singapore, Callio Therapeutics is focused on realising the promise of multi-payload antibody-drug conjugates to transform cancer patient outcomes. The company is developing next-generation, multi-payload antibody-drug conjugates (ADCs) that feature differentiated payload and linker technologies that enable targeted delivery of multi agents to tumor cells to maximize therapeutic benefit. Callio Therapeutics’ lead
Callio Therapeutics Read More »
Sunbird Bio is a biotechnology company developing proprietary blood-based diagnostic tests that provide unprecedented insights to enable earlier, more accurate diagnosis and treatment of neurological disorders and early-stage cancer. Sunbird’s innovative technologies uniquely detect the property and activity of proteins to empower researchers and clinicians with actionable information that is not available or accessible from
Dedicated to a ‘more human’ way to deliver radiation therapy, Leo Cancer Care emphasises on patient comfort and efficient treatment delivery, built on research showing the clinical benefits of upright positioning and patient rotation.
Leader in AI-enabled digital stethoscopes to aid early detection of cardiopulmonary diseases, Eko Health’s FDA-approved AI digital stethoscope, empowers healthcare professionals to swiftly and accurately detect and diagnose heart conditions.
Automera is an early-stage company specialising in autophagy-based protein degradation therapies, leveraging quantum chemistry and AI tools for drug development. Its AUTAC platform has potential in cancer and other diseases, with oncology as its initial focus.
Everest Medicines is a Hong Kong-listed (HKEX 1952.HK) biopharmaceutical company focused on developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in China and other Asian Pacific markets.
CXA Group is Asia’s first employee ecosystem platform for better health, wealth and wellness choices. Through the CXA platform, employers can empower employees with access to personalised health and lifestyle offerings, with clear and quantifiable ROI for the business. Founded in 2013 with the mission of transforming the delivery of employee benefits from pen-and-paper and
ConnexionsAsia (CXA Group) Read More »
Founded by Flagship Pioneering in 2018, Tessera Therapeutics is a life sciences innovation enterprise that conceives and develops first-in-category technologies to transform human health and sustainability. The company is pioneering a new approach in genetic medicine known as GENE WRITING technology.
Tessera Therapeutics Read More »
Neuroglee offers personalised digital therapeutics and virtual care solutions for neurodegenerative diseases.
Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.
Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.
